Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosis.
Journal: Scientific reports
Published: December 21, 2023
Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosis.
Journal: medRxiv : the preprint server for health sciences
Published: July 10, 2023
Dysregulation of humoral immunity, iron homeostasis, and lipid metabolism is associated with multiple sclerosis progression.
Journal: Multiple sclerosis and related disorders
Published: April 18, 2023
Teriflunomide modulates both innate and adaptive immune capacities in multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: January 30, 2023
Elevated sCD40L in Secondary Progressive Multiple Sclerosis in Comparison to Non-progressive Benign and Relapsing Remitting Multiple Sclerosis.
Journal: Journal of central nervous system disease
Published: May 24, 2021
Siponimod enriches regulatory T and B lymphocytes in secondary progressive multiple sclerosis.
Journal: JCI insight
Published: October 14, 2019
Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 07, 2016
Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: September 25, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026